8-Bromo-4-chloro-6-methylquinoline, 97%, 100mg

2-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole, 97%, 5g

(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol, 95.0%, 25g

3,5-Dibromo-4-hydroxybenzoic acid, 98.0%, 500g

2-(4-CHLOROPHENYL)-3-METHYL-N-(THIAZOL-2-YL)BUTANAMIDE, 97%, 50mg

4-Hydroxycyclohexanone, 97.0%, 250mg

2-Bromo-6-chloropyridin-3-amine, 97.0%, 10g

7-Azaindole, min 98%, 1 g, emballage verre

DBD-CO-Hz [=4-(N,N-Dimethylaminosulfonyl)-7-(N-hydrazinocarbonylmethyl-N-methyl)amino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

1-Chloro-3-(1,1-difluoroethyl)benzene, 1g

3-(Aminomethyl)-2-tert-butoxypyridine, 95.0%, 250mg

1-(2-Amino-3-methoxyphenyl)ethanone, 95.0%, 1g

N-(1H-1,2,3-Benzotriazol-1-ylmethyl)-9H-purin-6-amine, 1g